We performed a literature search of MEDLINE, Cochrane Library, and Web of Science to identify original, full-length research articles Background-The preferential citation of studies with the highest success rates could exaggerate perceived effectiveness, particularly for treatments with widely varying published success rates such as radiofrequency catheter ablation for atrial fibrillation. Methods and Results-We systematically identified observational studies and clinical trials of radiofrequency catheter ablation of atrial fibrillation between 1990 and 2012. Generalized Poisson regression was used to estimate association between study success rate and total citation count, adjusting for sample size, journal impact factor, time since publication, study design, and whether first or last author was a consensus-defined pre-eminent expert. We identified 174 articles meeting our inclusion criteria (36 289 subjects). After adjustment only for time since publication, a 10-point increase above the mean in pooled reported success rates was associated with a 17.8% increase in citation count at 5 years postpublication (95% confidence interval, 7.1-28.4%; P<0.001). After additional adjustment for impact factor, sample size, randomized trial design, and pre-eminent expert authorship, the association remained significant (18.6% increase in citation count; 95% confidence interval, 7.6-29.6%; P<0.0001). In this full model, time since publication, impact factor, and pre-eminent expert authorship were significant covariates, whereas randomized control trial design and study sample size were not. Conclusions-Among studies of radiofrequency catheter ablation of atrial fibrillation, high success rate was independently associated with citation count, which may indicate citation bias. To readers of the literature, radiofrequency catheter ablation of atrial fibrillation could be perceived to be more effective than the data supports. These findings may have implications for a wide variety of novel cardiovascular therapies. (Circ Cardiovasc Qual Outcomes. 2014;7:687-692.)
C itation bias is the selective citation of published results to support the findings, arguments, or interests of authors or other stakeholders. 1, 2 To the readers of medical literature, the preferential citation of studies with the highest success rates could exaggerate perceived success of a treatment.
There is a paucity of literature examining citation bias in the cardiovascular literature, 3 and new treatments may be susceptible, particularly if efficacy or safety varies widely across studies. Radiofrequency catheter ablation (RFA) for the treatment of atrial fibrillation (AF) may be vulnerable. During the past 25 years, numerous observational studies but scant randomized trials have evaluated the efficacy of RFA for AF. However, procedural success rates from these studies vary widely because of a variety of factors, including disease heterogeneity, patient selection, procedure technique, procedure tools, ascertainment and definitions of treatment success or failure, and follow-up time. Although several meta-analyses have generated overall point estimates, 4 selective emphasis of individual studies with very high or very low success rates could misrepresent the totality of evidence. We, therefore, sought to determine if study success rate was associated with citation count among studies of RFA for AF.
investigating RFA of AF from January 1, 2007, to January 1, 2012. We applied the search strategy of a previously published meta-analysis by Calkins et al, 4 which evaluated studies from 1990 to 2007. The replicated search strategy was tested by verifying that it would detect the studies identified by the Calkins study, with all relevant references from that study included in the present analysis. The final cohort of studies analyzed includes all studies meeting the search criteria from 1990 to 2012.
We excluded studies with pediatric patients, with <40 patients, or with ablation techniques other than catheter tip-based radiofrequency ablation. We also excluded studies in which the procedure success rate was not reported or could not be calculated and studies published in journals for which impact factors could not be obtained. We identified duplicate citation records on the basis of matching author names, article titles, and journal names, electronically (Endnote software version X4.0; Thomson Reuters, Carlsbad, CA) and manually. Articles of subcohorts were excluded if an article using the entire cohort was previously included. When the same research study was found in multiple journals or repositories, only 1 instance of the study was included. The search strategy is detailed in Table I in the Data Supplement.
Data Collection
Study selection and data abstraction were completed by a single investigator (A.C.P.) and independently reviewed and verified by 2 additional investigators (D.H., P.S.). We abstracted data regarding study design, inclusion and exclusion criteria, sample size, presence of randomized control trial (RCT) design, ablation procedure, month and year of publication, total number of citations (according to Web of Science [Thomson Reuters, New York, NY] on November 15, 2012), and the impact factor of the journal in which the study was published (according to the Web of Knowledge [Thomson Reuters] as of November 15, 2012). We also abstracted whether the first or last author was a pre-eminent expert, to account for possible preferential citation of articles from experts well known in the field. Pre-eminent experts were defined by consensus of the authors (M.P.T., P.J.W., M.V.P.) who perform AF ablation and were Hugh Calkins, Michel Haissaguerre, Fred Morady, Andrea Natale, and Carlo Pappone. In some studies, success rates were reported after the initial AF ablation procedure and after repeat or multiple ablation procedures. In these cases, we conservatively abstracted success rates after a single (first) procedure. Our rationale is that single-procedure success rates are generally used to evaluate procedural efficacy. For studies reporting only a success rate after multiple procedures, we used that success rate but retained a variable in our models for single-versus multiple-procedure reporting and an interaction term for this variable multiplied by the success rate. If reported, we used the success rate of complete freedom from atrial tachyarrhythmia off antiarrhythmic drugs in the analysis. If a study contained groups of patients, we calculated a single pooled success rate. If a single or multiple procedure(s) success rate was not explicitly stated in a study, but could be calculated with certainty from the data presented in the study, then we included the calculated success rate in the analysis. If there was no indication that multiple procedures were performed, we assumed that only a single procedure had been performed. If a study included people who had previously undergone ablation, but the study itself only performed a single ablation procedure, then we treated the data as a single procedure. Disagreements were resolved by consensus with a third reviewer (M.P.T.). Studies with extreme citation frequencies were reviewed on an individual basis.
Statistical Analysis
The primary outcome was the total citation count. Citation count was regressed on pooled reported procedure success rates, 6 additional covariates, and an interaction term via nonlinear Poisson regression with a logarithmic link. 5 Mean citation count (intensity), λ, was modeled as λ α β = ( ) ( ) exp exp t , which allowed for exponential growth in counts in years t since publication (difference between the year the study was published and date that citation counts were obtained) as well as variation among articles at the time of publication because of covariates
).
Covariates were (1) success rate, R, for maintaining sinus rhythm; (2) number of patients, N, included in the study; (3) impact factor, I, of the journal in which the study was published; (4) whether the first or last author was a pre-eminent expert, E; (5) presence of RCT study design, D; (6) whether study reported multiple procedure success rate only, M; and (7) interaction term of variables R and M. Covariates were centered and scaled before regression analysis to facilitate fitting algorithm convergence. We reported the percent increase in mean quantity of citations at 5 years after publication for increases in respective variables (ie, 10% increase in success rate, 1 U increase in impact factor, 10 U increase in sample size, and presence of RCT study design). To present the data as percent increases, we held t constant at 5 years and transformed the corresponding percent difference back to the original scale. A Poisson distribution is discrete-valued with large values being rare, which often provides a suitable approximation to count data. 6 Despite allowance for an exponential rate of growth in citations, variance in counts about the fitted mean exceeded that for a Poisson distribution. Attempts to fit a finite mixture 7 failed to identify the presence of >1 Poisson distribution. Therefore, we used a generalized Poisson distribution, which included an additional parameter, η, that allows for overdispersion in counts. 8 A plot of studentized residuals against fitted values revealed no trend in the mean of the residuals or in the spread of residuals about zero, indicating that the model for the mean and variance is specified correctly ( Figure I in the Data Supplement). We reported models including and excluding the pre-eminent expert variable, because of the subjective nature of selecting these experts. Stata version 11 (StataCorp, College Station, TX) and SAS version 9.3 (SAS Institute, Cary, NC) were used for analysis.
Results
We identified 175 articles meeting our inclusion criteria. A complete list of studies and study characteristics are shown in
WHAT IS KNOWN
• Citation bias, defined as the preferential citation of studies with the highest efficacy or effectiveness, can exaggerate the perceived effect of interventions by preferential citation of significant studies. • To readers of the medical literature, this preferential citation could exaggerate perceived success of a treatment, particularly for interventions with widely varying published success rates, such as catheter ablation of atrial fibrillation.
WHAT THE STUDY ADDS
• In an analysis of 174 studies of radiofrequency catheter ablation of atrial fibrillation spanning 22 years, we found an independent association between study success rates and total citation count, even after adjustment for sample size, journal impact factor, authorship by a pre-eminent expert, randomized control trial design, and time since publication. • Our findings extend the work of prior studies by demonstrating that preferential citation relates not just to whether a study has a statistically significant result but also to the magnitude of the reported effect size • To readers of the literature, atrial fibrillation ablation may seem more effective than is supported by the totality of evidence, and these findings may have implications for a wide variety of novel cardiovascular therapies.
Tables II and III in the Data Supplement. Examination of the distributions of the outcome variable (total citation) showed 1 outlier article by Haissaguerre et al 9 with 2694 citations (2006 more than the second most cited article at 688). Because this article is considered a seminal article on AF ablation 10 (and, therefore, disproportionately more likely to be cited), we excluded this article from further analyses (Figure) . No articles were excluded based on model fit.
In the remaining 174 articles, there were 36 289 subjects: 127 articles (n=25 742) reporting results after a single ablation procedure; 117 articles (n=23 722) reporting results after multiple ablation procedures. Of these, 70 articles (n=13 175) reported results for both single and multiple procedures. Thirty-six articles used a RCT study design. There was wide variation in reported success rates, ranging from 10% to 92% (mean 61±18%) after single ablations and 31% to 95% (mean 73±14%) after multiple ablations. The mean pooled success rate was 69.7±16.6% among studies with pre-eminent expert first or last authorship and 61.4±17.0% among studies without pre-eminent expert authorship (P=0.006). The mean pooled success rate was 61.8±16.0% among studies with RCT design and 63.9±17.6% among studies without RCT design (P=0.511). The mean citation counts were 53.5 for single-procedure studies and 54.0 for multiple-procedure studies.
After adjustment for only time since publication, a 10-point increase above the mean in pooled reported success rates was associated with a 17.8% (95% confidence interval, 7.1-28.4%; P=0.001) increase in mean quantity of citations at 5 years. After adjustment for covariates, a 10-point increase above the mean in pooled reported success rate was associated with an 18.6% (95% confidence interval, 7.6-29.6%; P=0.001) increase in mean quantity of citations at 5 years. There was no association with multiple procedure reporting, and the interaction term of success rate and multiple procedure reporting was not significant. Journal impact factor, authored by pre-eminent expert, and time since publication were significant covariates, whereas sample size (in the regression including pre-eminent expert status) and RCT study design were not (Table) .
Discussion
In an analysis of 174 studies of RFA of AF spanning 22 years, we found an association between the pooled success rates and total citations, adjusted for time since publication. After additional adjustment for sample size, journal impact factor, authorship by a pre-eminent expert, RCT study design, and time since publication, the association between study success rate and citation count remained significant. These data indicate preferential citation of studies with higher success rates.
Publication bias, defined as the preferential publication of studies reporting a positive effect (ie, significant results), is a well-recognized source of bias that affects medical literature. Previous studies have suggested that citation bias, through a different mechanism than publication bias, can exaggerate the perceived effect of interventions by preferential citation of significant studies. 3, [11] [12] [13] [14] [15] Journal prestige and impact factors are common contributors to citation bias, 16, 17 but our analysis demonstrated an association between pooled success rates and citation count even after adjustment for these factors. Our findings extend the work of prior studies by demonstrating that preferential citation relates not just to whether a study has a statistically significant result but also to the magnitude of the reported effect size (RFA AF success rate).
To our knowledge, this is the first examination of outcomecitation associations for cardiovascular procedures. At a time when technology diffusion is rapid and publication volume has risen exponentially, 18 these findings may have implications for a wide variety of cardiovascular therapies, particularly for interventions with rapid uptake for which there is limited randomized trial data, including transcatheter aortic valves, ventricular assist devices, and renal denervation. CI indicates confidence interval. *Binary variable indicating whether a study reported a multiple procedure ablation success rate only. †An interaction term for single vs multiple ablation procedure reporting multiplied by ablation success rate was added to the regression models. The interaction term is not statistically significant in all models suggesting that abstracting ablation success rate after a single procedure, and after multiple procedures only when single procedure success rate was not reported, may be a valid method of abstracting data ‡Pre-eminent experts were defined by consensus of the authors who perform atrial fibrillation ablation (M.P.T., P.J.W., M.V.P.), and included Calkins, Haissaguerre, Morady, Natale, and Pappone.
The downstream effects of citation bias have been previously described in an analysis by Greenberg, 19 who performed a citation network analysis for all publications discussing β-amyloid protein in inclusion body myositis. In this analysis, the investigator reviewed every citation of every included study to determine if a citation was supportive, neutral, or critical of an objective measure. This type of analysis allows a more contextual assessment of bias, rather than demonstration of associations, as we have shown. Greenberg not only identified the presence of citation bias; he demonstrated that through citation distortion (a concept that includes citation bias), information cascades can be created resulting in unfounded authority of claims. This study highlights the power that misleading citation practices have, in particular citation bias, to create a false belief system among the scientific community.
Preferential citation may be deliberate or the unintended consequence of the scientific process. It is deliberate if authors are selectively citing the most favorable studies despite an awareness of less favorable studies. On the contrary, if authors merely cite studies familiar to them in an absence of a thorough literature review, then recall bias can occur, which may not have been intentional. Both these reasons may explain why the seminal article on AF ablation 9 was so disproportionally cited. First or last authorship by a pre-eminent expert was strongly associated with citation intensity. This finding may be the result of published studies citing pre-eminent experts as a surrogate for study quality or impact, because the success rate of studies with pre-eminent expert authorship was higher than studies without. However, the association may also indicate the absence of systematic literature reviews, with specific preeminent experts cited as a consequence of recall bias. This observation merits further investigation.
For this analysis, we did not directly measure study quality, although we did evaluate 3 characteristics that are often perceived as related to study quality: RCT design, study sample size, and journal impact factor. We found that RCT study design was not associated with citation count. Study sample size was associated with citation count, but with a very small effect size (0.5% increase in citations at 5 years for 10-U increase in sample size; P=0.011). After adjustment for authorship by a pre-eminent expert, the association was no longer significant. Impact factor, which was significantly associated with citation count, could be reflective of study quality to some degree, but can also be heavily influenced by other factors.
Combating the negative effects of citation bias will be challenging, although increased awareness by readers, reviewers, and investigators might help. Jannot et al 15 recommend that journals encourage authors to cite systematic reviews (as opposed to citing original research) and even perform systematic reviews (as opposed to mining individual articles for references) to minimize the likelihood of citation bias. However, in the case of such systematic reviews or meta-analyses, methodology could bias study selection if researchers supplement searches of computerized databases by checking reference lists of other studies or by contacting key opinion leaders, both of which may be more likely to locate supportive studies. 2 One possible first step may be to require that authors attest that literature reviews were systematically performed and that a range of results are reported if multiple relevant references were identified.
There are several limitations to our study. Unidentified confounders could potentially explain the association between citation count and success rate, for example, if higher quality studies, preferred patient populations, or more widely adopted ablation strategies were more represented among highly cited studies. An association between citation count and success rate, although suggestive of citation bias, cannot establish causation. Although our methods accounted for nonlinearity and overdispersion in citation counts, it is possible that some extreme values could disproportionally influence model fit, although results were consistent across log-transformed citation correlations and Poisson regressions. Endogeneity may be present in our regressions (eg, success rate may influence journal acceptance/impact factor). We analyzed cumulative citation counts and did not use longitudinal data on annual citation accrual.
In conclusion, for RFA of AF, we found preferential citation of studies with higher procedural success rates, suggesting citation bias. The association was independent of sample size, journal impact factor, authored by pre-eminent expert, and time since publication. To readers of literature, AF ablation may seem more effective than is supported by the totality of data, and these findings may have implications for a wide variety of novel cardiovascular therapies.
